XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Cash Flows from Operating Activities                    
Net loss $ (93.5) $ (171.9) $ (19.1) $ (33.5) $ (265.4) $ (52.6)        
Loss from discontinued operations, net of tax (5.1)   (13.2)   (9.8) (22.7)        
Loss from continuing operations, net of tax (88.4)   (5.9)   (255.6) (29.9)        
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:                    
Depreciation         30.2 36.5        
Amortization         13.1 12.8        
Provision for doubtful accounts         52.7 58.7        
Provision for obsolescence         21.4 16.2        
Share-based compensation         18.6 5.2        
Foreign exchange losses (gains)         25.7 (7.3)        
Deferred income taxes         14.9 7.3        
Impairment loss on assets         0.7 13.3        
Gain on sale of business / assets (0.1)   (13.2)   (0.1) (23.5)        
Other         13.2 5.2        
Changes in assets and liabilities:                    
Accounts receivable         36.8 (40.9)        
Inventories         (52.6) 18.0        
Prepaid expenses and other         (12.0) 15.2        
Accounts payable and accrued liabilities         (191.7) (211.3)        
Income and other taxes         (23.7) 7.2        
Noncurrent assets and liabilities         (15.8) (18.3)        
Net cash used by operating activities of continuing operations         (324.2) (135.6)        
Cash Flows from Investing Activities                    
Capital expenditures         (21.1) (32.5)        
Disposal of assets         1.1 0.8        
Net proceeds from sale of business / assets         10.0 76.5        
Other investing activities         0.4 0.0        
Net cash (used) provided by investing activities of continuing operations         (9.6) 44.8        
Cash Flows from Financing Activities                    
Cash dividends         (8.6) 0.0        
Debt, net (maturities of three months or less)         10.1 0.5        
Proceeds from debt         20.0 0.0        
Repayment of debt         (0.2) (0.3)        
Repurchase of common stock         (0.4) (1.1)        
Settlement of stock options         (25.8) 0.0        
Other financing activities         0.0 (9.2)        
Net cash used by financing activities of continuing operations         (4.9) (10.1)        
Net cash used by operating activities of discontinued operations         (8.4) (4.6)        
Net cash used by discontinued operations         (8.4) (4.6)        
Effect of exchange rate changes on cash and cash equivalents, and restricted cash         (17.4) (2.3)        
Net decrease in cash and cash equivalents, and restricted cash         (364.5) (107.8)        
Cash and cash equivalents, and restricted cash at beginning of year [1]   661.0   536.4 661.0 536.4 $ 536.4      
Cash and cash equivalents, and restricted cash at end of period 296.5 [2]   428.6 [2]   296.5 [2] 428.6 [2] 661.0 [1]      
Cash and cash equivalents, classified as held for sale                   $ 3.7
Cash and cash equivalents               $ 285.8 $ 650.6  
Restricted cash               10.7 2.9  
Long-term restricted cash [3]               0.0 7.5  
Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows $ 296.5 [2] $ 661.0 [1] $ 428.6 [2] $ 536.4 [1] $ 661.0 [1] $ 428.6 [2] $ 661.0 [1] $ 296.5 [2] $ 661.0 [1] $ 428.6 [2]
[1] The balance at the beginning of the six-month period ended June 30, 2019 includes cash and cash equivalents of $3.7 classified as Held for sale assets in our Consolidated Balance Sheets.
[2] The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheet that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows for the six-month period ended June 30, 2020.
June 30, 2020December 31, 2019
Cash and cash equivalents$285.8  $650.6  
Restricted cash10.7  2.9  
Long-term restricted cash(1)
—  7.5  
Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows$296.5  $661.0  

(1) Long-term restricted cash is presented in other assets in our Consolidated Balance Sheets. The balance of $7.5 as of December 31, 2019 resulting from the sale of Avon Manufacturing (Guangzhou), Ltd has been reclassified to short-term restricted cash as of June 30, 2020.
[3] Long-term restricted cash is presented in other assets in our Consolidated Balance Sheets. The balance of $7.5 as of December 31, 2019 resulting from the sale of Avon Manufacturing (Guangzhou), Ltd has been reclassified to short-term restricted cash as of June 30, 2020.